View in EDS

Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.

Saved in:
Bibliographic Details
Title: Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
Authors: Aizenbud L; Medical Oncology, Yale University, New Haven, Connecticut, USA., Savion Gaiger N; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Perdigoto AL; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Internal medicine, VA Connecticut Healthcare System, West Haven, Connecticut, USA., Mann JE; Medical Oncology, Yale University, New Haven, Connecticut, USA., Torres MC; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA., Boland GM; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA., Lawless AR; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Silverman S; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA., Schoenfeld DA; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Destina JI; Yale University, New Haven, Connecticut, USA., Hasson N; Medical Oncology, Yale University, New Haven, Connecticut, USA., Tran T; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Hurwitz M; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA., Austin MR; Medical Oncology, Yale University, New Haven, Connecticut, USA., Sullivan RJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Herold KC; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Immunology, Yale University, New Haven, Connecticut, USA., Kluger HM; Medical Oncology, Yale University, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Sep 10; Vol. 13 (9). Date of Electronic Publication: 2025 Sep 10.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40935567
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Aizenbud+L%22">Aizenbud L</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Savion+Gaiger+N%22">Savion Gaiger N</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Perdigoto+AL%22">Perdigoto AL</searchLink>; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Internal medicine, VA Connecticut Healthcare System, West Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mann+JE%22">Mann JE</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Torres+MC%22">Torres MC</searchLink>; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Boland+GM%22">Boland GM</searchLink>; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Lawless+AR%22">Lawless AR</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Silverman+S%22">Silverman S</searchLink>; Department of Genetics, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Schoenfeld+DA%22">Schoenfeld DA</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Destina+JI%22">Destina JI</searchLink>; Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Hasson+N%22">Hasson N</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Tran+T%22">Tran T</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Hurwitz+M%22">Hurwitz M</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Austin+MR%22">Austin MR</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Sullivan+RJ%22">Sullivan RJ</searchLink>; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Herold+KC%22">Herold KC</searchLink>; Endocrinology and Metabolism, Yale University, New Haven, Connecticut, USA.; Immunology, Yale University, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Kluger+HM%22">Kluger HM</searchLink>; Medical Oncology, Yale University, New Haven, Connecticut, USA Harriet.Kluger@Yale.edu.; Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Sep 10; Vol. 13 (9). <i>Date of Electronic Publication: </i>2025 Sep 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40935567
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2025-012358
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Aizenbud L
      – PersonEntity:
          Name:
            NameFull: Savion Gaiger N
      – PersonEntity:
          Name:
            NameFull: Perdigoto AL
      – PersonEntity:
          Name:
            NameFull: Mann JE
      – PersonEntity:
          Name:
            NameFull: Torres MC
      – PersonEntity:
          Name:
            NameFull: Boland GM
      – PersonEntity:
          Name:
            NameFull: Lawless AR
      – PersonEntity:
          Name:
            NameFull: Silverman S
      – PersonEntity:
          Name:
            NameFull: Schoenfeld DA
      – PersonEntity:
          Name:
            NameFull: Destina JI
      – PersonEntity:
          Name:
            NameFull: Hasson N
      – PersonEntity:
          Name:
            NameFull: Tran T
      – PersonEntity:
          Name:
            NameFull: Hurwitz M
      – PersonEntity:
          Name:
            NameFull: Austin MR
      – PersonEntity:
          Name:
            NameFull: Sullivan RJ
      – PersonEntity:
          Name:
            NameFull: Herold KC
      – PersonEntity:
          Name:
            NameFull: Kluger HM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 10
              M: 09
              Text: 2025 Sep 10
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1